Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Japanese Yen: Pressure persists toward 162 against US Dollar – Scotiabank

Japanese Yen: Pressure persists toward 162 against US Dollar – Scotiabank

FXStreetFXStreet2026/06/11 15:21
By:FXStreet

Scotiabank strategists Shaun Osborne and Eric Theoret report USD/JPY is steady but elevated, with recent gains already surpassing prior intervention-trigger levels. A 25 bps Bank of Japan (BoJ) hike on Tuesday is widely anticipated, and markets price nearly one more increase by December. They flag concerns over communication as Governor Ueda will not attend, and see limited resistance up to 162 with support in the 156–158 band.

Yen weakness raises intervention concerns

"The yen’s ongoing weakness is a worry for market participants, government officials, and central bank policymakers, sparking concerns of intervention in the former as the latter consider the implications for inflation."

"The latest weakness in spot (gains for USD/JPY) have already cleared levels that sparked earlier currency management activities (price checking in January, intervention in late April/early May)."

"Domestic releases have been limited and ahead of Tuesday’s BoJ rate decision. A 25 bps hike is widely anticipated and markets are pricing nearly one additional hike by December."

"Gov. Ueda is not attending, leaving market participants somewhat concerned about the central bank’s communication specifically the post meeting press conference."

"For USD/JPY, we see limited resistance between current spot and 162 and we would anticipate support in the 156/158 range."

(This article was created with the help of an Artificial Intelligence tool and reviewed by an editor.)

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Novo Nordisk (NVO.US) unveils $23 billion pipeline blueprint, but the market isn't buying it! Investors ask, "How to turn the tide against adversity?"

After being surpassed by Eli Lilly in the obesity market, Novo Nordisk failed to present a concrete turnaround plan to CEO Mike Doustdal, disappointing investors. The company has pledged to launch more than five blockbuster drugs in the coming years and achieve over $23 billion in new sales, but the press conference lacked details on how to drive growth.

智通财经2026/09/21 09:31
Novo Nordisk (NVO.US) unveils $23 billion pipeline blueprint, but the market isn't buying it! Investors ask, "How to turn the tide against adversity?"

STONK hits new highs after erasing 27% crash

Cryptopolitan2026/09/21 09:30
STONK hits new highs after erasing 27% crash

25 Days, Four Launches in Sight! Rocket Lab (RKLB.US) Accelerates Rocket Launches to Advance Its Ambitious "Space AI Infrastructure" Goals

After another successful mission, Rocket Lab's 97th Electron rocket is now positioned at the launch pad. This flight will be Rocket Lab's fourth launch in 25 days and its 18th launch in 2026.

智通财经2026/09/21 08:41